BRIEF published on 07/11/2024 at 07:10, 1 year 6 months ago Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business Financial Results Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma
BRIEF published on 07/11/2024 at 07:10, 1 year 6 months ago Heidelberg Pharma rend compte du premier semestre 2024 et de la marche des affaires Résultats Financiers Essai Clinique Heidelberg Pharma HDP-101 Myélome Multiple
PRESS RELEASE published on 07/11/2024 at 07:05, 1 year 6 months ago Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business Heidelberg Pharma AG reports positive preliminary efficacy data for HDP-101 in multiple myeloma clinical trial. Key events include AACR Meeting presentation & FDA Orphan Drug Designation Clinical Trial HDP-101 Heidelberg Pharma AG AACR Meeting FDA Orphan Drug Designation
BRIEF published on 06/21/2024 at 11:21, 1 year 7 months ago Heidelberg Pharma Reports on the Results of the Annual General Meeting 2024 Shareholders Financial News Resolutions Heidelberg Pharma AGM 2024
BRIEF published on 06/21/2024 at 11:21, 1 year 7 months ago Heidelberg Pharma rend compte des résultats de l'Assemblée générale annuelle 2024 Actionnaires Resolutions Heidelberg Pharma Actualités Financières AGA 2024
PRESS RELEASE published on 06/21/2024 at 11:16, 1 year 7 months ago Heidelberg Pharma reports on the results of the Annual General Meeting 2024 Heidelberg Pharma AG reports on the results of the Annual General Meeting 2024, including approval of resolutions and shareholder attendance Shareholders Voting Results Annual General Meeting 2024 Cancer Therapy Heidelberg Pharma AG
BRIEF published on 06/18/2024 at 13:52, 1 year 7 months ago Heidelberg Pharma AG Announces Updated Guidance for 2024 Revenue Forecast Financial Guidance Biotech Heidelberg Pharma AG Operating Expenses
BRIEF published on 06/18/2024 at 13:52, 1 year 7 months ago Heidelberg Pharma AG annonce des prévisions mises à jour pour 2024 Conseils Financiers Prévisions De Revenus Heidelberg Pharma SA Biotechnologies Dépenses De Fonctionnement
PRESS RELEASE published on 06/18/2024 at 13:47, 1 year 7 months ago EQS-Adhoc: Heidelberg Pharma AG announces updated guidance Heidelberg Pharma AG updates guidance for fiscal year 2024, lowering sales expectations due to delays and adjusting operating expenses. Financing secured until mid-2025 with potential expansion until end of 2026 Financial Year 2024 Heidelberg Pharma AG Operating Expenses Sales Expectations Updated Guidance
BRIEF published on 05/23/2024 at 09:17, 1 year 8 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Cancer Treatment Conférences Heidelberg Pharma HDP-101 ADCs
Published on 02/10/2026 at 15:30, 17 minutes ago Predictiv AI Establishes Asia Regional Office to Support Expansion Across Asia, Africa, and the Middle East
Published on 02/10/2026 at 15:00, 47 minutes ago Haven Safety AI Launches AI-Native Safety Intelligence Platform Co-Founded with The AES Corporation and AI Fund
Published on 02/10/2026 at 14:30, 1 hour 17 minutes ago Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/10/2026 at 14:00, 1 hour 47 minutes ago Horizon Aircraft Partners with North Aircraft Industries to Manufacture the Wings for the Cavorite X7
Published on 02/10/2026 at 15:30, 17 minutes ago Nebius announces agreement to acquire Tavily to add agentic search to its AI cloud platform
Published on 02/10/2026 at 15:15, 32 minutes ago Kasowitz and Mishcon de Reya Comment on Tirana Mayor Erion Veliaj's Year in Detention: For 365 Days and Counting, Mayor Veliaj Suffers Denials of Due Process Rights and Apparent Political Persecution
Published on 02/10/2026 at 15:09, 38 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 02/09/2026 at 18:00, 21 hours 47 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 22 hours 2 minutes ago Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 22 hours 2 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 22 hours 2 minutes ago Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 22 hours 2 minutes ago Déclaration des droits de vote à fin janvier 2026
